Ovid Therapeutics Names Former Biogen Exec New CMO

Xconomy New York — 

New York-based Ovid Therapeutics has named Amit Rakhit, a former Biogen and Bristol-Myers Squibb executive, its chief medical and portfolio management officer. The company has also added Daniel Geschwind, a neurology and psychiatry professor at UCLA School of Medicine, to its scientific advisory board. Check out this story for more on Ovid, which is developing drugs for rare neurological diseases such as Angelman Syndrome.